Clinical characteristics and antimicrobial susceptibility of invasive group B streptococcal infections in nonpregnant adults in Taiwan

Journal of the Formosan Medical Association

Volumn 96, Issue 8, 1997, Pages 628-633

  Liu, Jien Wei ^a   Wu, Jiunn Jong ^b   Ko, Wen Chien ^a,b   Chuang, Yin Ching ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial resistance; Invasive group B streptococcal disease; Penicillin G

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; BACITRACIN; CEFALOTIN; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; ENOXACIN; ERYTHROMYCIN; GENTAMICIN; OFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CLINICAL ARTICLE; DIABETES MELLITUS; DILUTION; FEMALE; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; SOFT TISSUE INFECTION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0030801654     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Eickhoff TC, Klein JO, Daly AL, et al: Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. New Engl J Med 1964;271:1221-8.
2. Bayer AS, Chow AW, Anthony BF, et al: Serious infections in adults due to group B streptococci: clinical and serotypic characterization. Am J Med 1976;61:498-503.
3. Edwards MS, Baker CJ: Streptococcus agalacfiae (group B streptococcus). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone, 1995:1835-45.
4. Zangwill KM, Schuchat A, Wenger JD: Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR Morb Mortal Wkly Rep 1992;41:25-32.
5. Schwartz B, Schuchat A, Oxtoby MJ, et al: Invasive group B streptococcal disease in adults: a population-based study in metropolitan Atlanta. J Am Med Assoc 1991; 266:1112-4.
6. Jackson LA, Hilsdon R, Farley MM, et al: Risk factors for group B streptococcal disease in adults. Ann Intern Med 1995;123:415-20.
7. Farley MM, Harvey RC, Stull T, et al: A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. New Engl J Med 1993;328:1807-11.
8. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. "NCCLS document no. M7-A3". Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1994.
10. Pugh RNH, Murray-Lyon IM, Dawson JL, et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.
11. Verghese A, Mireault K, Arbeit RD: Group B streptococcal bacteremia in men. Rev Infect Dis 1986; 8:912-7.
12. McCarty JM, Haber J: Group B streptococcal soft tissue infections beyond the neonatal period. West J Med 1987;147:558-60.
13. Riefler J III, Molavi A, Schwartz D, et al: Necrotizing fasciitis in adults due to group B streptococcus: report of a case and review of the literature. Arch Intern Med 1988;148:727-9.
14. Weiss RL, Masten JM: Group B streptococcal breast abscess. Arch Pathol Lab Med 1987;111:74-5.
15. Sischo WM, Heider LE, Miller GY, et al: Prevalence of contagious pathogens of bovine mastitis and use of mastitis control practices. J Am Vet Med Assoc 1993;202:595-600.
16. Nolan CM, Beaty HN, Bagdade JD: Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 1978;27:889-94.
17. Casey JI, Maturlo S, Albin J, et al: Comparison of carriage rates of group B streptococci in diabetic and nondiabetic persons. Am J Epidemiol 1982;116:704-8.
18. Chen DC, Lai MY, Lee SC, et al: Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan. J Med Virol 1986;19:87-94.
19. Chuang CY, Chang PY, Lin KC: AIDS in the Republic of China, 1992. Clin Infect Dis 1993;17:S337-40.
20. Kim KS: Antimicrobial susceptibility of GBS. Antibiot Chemother 1985;35:83-9.
21. Hsueh PR, Chen HM, Huang AH, et al: Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 1995;39:2239-42.
22. Benson CA, Segreti J, Beaudette FE, et al: In vitro activity of A-56268 (TE-031), a new macrolide. compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrob Agents Chemother 1987;31:328-30.
23. Bahal N, Nahata MC: The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother 1992;26:46-55.
24. Rolston KVI: Susceptibility of group B and group G streptococci to newer antimicrobial agents. Eur J Clin Microbiol 1986;4:534-6.
25. Schauf C, Deveikis A, Riff L, et al: Antibiotic-killing kinetics of group B streptococci. J Pediatr 1976;89:194-8.
26. Baker CN, Thornsberry C, Facklam RR: Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob Agents Chemother 1981;19:716-25.
27. Allen JL, Sprunt K: Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B β-hemolytic streptococci. J Pediatr 1978;93:69-71.
28. Kim KS, Anthony BF: Penicillin tolerance in group B streptococci isolated from infected neonates J Infect Dis 1981;144:411-9.
29. Gallagher PG, Watanakunakorn C: Group B streptococcal endocarditis: report of seven cases and review of the literature, 1962-1985. Rev Infect Dis 1986;8:175-88.
30. Steinbrecher UP: Serious infection in an adult due to penicillin-tolerant group B streptococcus. Arch Intern Med 1981;141:1714-5.